Presentation TCT 2015 Device-Based Therapies for Hypertension Treatment: Procedural Aspects Presenter: Ajay J. Kirtane, Felix Mahfoud, Farrell O. Mendelsohn October 11, 2015
Presentation TCT 2015 Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment Presenter: Ajay J. Kirtane, Felix Mahfoud, Michael A. Weber October 11, 2015
News Features TCT 2014 Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease Todd Neale October 31, 2014
News Features TCT 2014 Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease Todd Neale October 24, 2014
Presentation TCT 2014 Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston September 16, 2014
Presentation TCT 2014 What Is the Clinical Trial Pathway Moving Forward for Renal Denervation? Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka September 16, 2014
Presentation TCT 2014 Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Felix Mahfoud September 16, 2014
Presentation TCT 2014 New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt September 16, 2014
Presentation TCT 2014 Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes? Presenter: George D. Dangas, Michael E. Farkouh, Usman Baber September 16, 2014
Presentation TCT 2014 Clinical Trial Updates: RenalGuard, AVERT, etc. Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon September 16, 2014
Presentation TCT 2014 Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch September 16, 2014
Presentation TCT 2014 Unfavourable Anatomy Of Renal Arteries Should Not Be An Exclusion Criteria For Renal Sympathetic Denervation Presenter: Alexander Plehn September 16, 2014
Presentation TCT 2014 Second generation devices for renal denervation give better renal blood flow when compared with 1st generation catheters Presenter: Waleed Kadro September 16, 2014
Presentation TCT 2014 CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS Presenter: Daniel Garcia September 16, 2014
Presentation TCT 2014 Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days Presenter: Gregory Wilson September 16, 2014
Presentation TCT 2014 Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study Presenter: Robert Whitbourn September 16, 2014
Presentation TCT 2014 24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___ Presenter: Alexander Plehn September 16, 2014